Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option

Immunotherapy is one of the promising strategies in the treatment of oncology. Immune checkpoint inhibitors, as a type of immunotherapy, have no significant efficacy in the clinical treatment of patients with pMMR/MSS/MSI-L mCRC alone. Therefore, there is an urgent need to find combination therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yi, Miao, Jia-Meng, Wang, Yuan-Yuan, Fan, Zheng, Kong, Xian-Bin, Yang, Long, Cheng, Gong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334725/
https://www.ncbi.nlm.nih.gov/pubmed/35911673
http://dx.doi.org/10.3389/fimmu.2022.961796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334725/
https://www.ncbi.nlm.nih.gov/pubmed/35911673
http://dx.doi.org/10.3389/fimmu.2022.961796

Ejemplares similares